NCT03980509 A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors Status COMPLETED Phase PHASE1
NCT03980093 The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors Status COMPLETED Phase NA
NCT03980054 A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer Status UNKNOWN Phase PHASE3
NCT03975959 Memory Perception Assessment in Central/Non-central Nervous System Cancers Status COMPLETED Phase NA
NCT03975179 Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery Status RECRUITING Phase NA
NCT03974204 Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. Status WITHDRAWN Phase NA
NCT03973034 Clinical Application of ctDNA in Early Screening of Breast Cancer Status UNKNOWN Phase N/A
NCT03972696 OPTimizing Irradiation Through Molecular Assesment of Lymph Node After Primary Systemic Treatment Status TERMINATED Phase NA
NCT03972020 Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast Cancer Status UNKNOWN Phase NA
NCT03971045 Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer Status RECRUITING Phase PHASE2
NCT03964532 TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03961698 Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03960463 EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds Status COMPLETED Phase NA
NCT03959891 AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) Status ACTIVE_NOT_RECRUITING Phase PHASE1